Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.

West NP, Thomson SA, Triccas JA, Medveczky CJ, Ramshaw IA, Britton WJ.

Vaccine. 2011 Oct 13;29(44):7759-65. doi: 10.1016/j.vaccine.2011.07.109. Epub 2011 Aug 16.

PMID:
21846485
2.

A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.

Ranasinghe C, Eyers F, Stambas J, Boyle DB, Ramshaw IA, Ramsay AJ.

Vaccine. 2011 Apr 5;29(16):3008-20. doi: 10.1016/j.vaccine.2011.01.106. Epub 2011 Feb 23.

3.

Evaluating vaccinia virus cytokine co-expression in TLR GKO mice.

Sutherland DB, Ranasinghe C, Regner M, Phipps S, Matthaei KI, Day SL, Ramshaw IA.

Immunol Cell Biol. 2011 Aug;89(6):706-15. doi: 10.1038/icb.2010.157. Epub 2010 Dec 21.

PMID:
21173782
4.

Human immunodeficiency virus-1 vaccine design: where do we go now?

Wijesundara DK, Jackson RJ, Ramshaw IA, Ranasinghe C.

Immunol Cell Biol. 2011 Mar;89(3):367-74. doi: 10.1038/icb.2010.118. Epub 2010 Oct 19. Review.

PMID:
20956986
5.

Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.

Ranasinghe C, Ramshaw IA.

Expert Rev Vaccines. 2009 Sep;8(9):1171-81. doi: 10.1586/erv.09.86. Review.

PMID:
19722891
6.

Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity.

Ranasinghe C, Ramshaw IA.

Eur J Immunol. 2009 Jul;39(7):1819-30. doi: 10.1002/eji.200838995.

7.

Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy.

Day SL, Ramshaw IA, Ramsay AJ, Ranasinghe C.

J Immunol. 2008 Jun 1;180(11):7158-66.

8.

Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies.

Rollman E, Smith MZ, Brooks AG, Purcell DF, Zuber B, Ramshaw IA, Kent SJ.

J Immunol. 2007 Oct 1;179(7):4571-9.

9.

Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles.

Ranasinghe C, Turner SJ, McArthur C, Sutherland DB, Kim JH, Doherty PC, Ramshaw IA.

J Immunol. 2007 Feb 15;178(4):2370-9. Erratum in: J Immunol. 2007 Jun 15;178(12):8221.

10.

Exploiting 4-1BB costimulation for enhancing antiviral vaccination.

Harrison JM, Bertram EM, Ramshaw IA.

Viral Immunol. 2006 Winter;19(4):593-601. Review.

PMID:
17201654
11.

Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2.

Rolph MS, Young TR, Shum BO, Gorgun CZ, Schmitz-Peiffer C, Ramshaw IA, Hotamisligil GS, Mackay CR.

J Immunol. 2006 Dec 1;177(11):7794-801.

12.

Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.

De Rose R, Batten CJ, Smith MZ, Fernandez CS, Peut V, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Venturi V, Davenport MP, Kent SJ.

J Virol. 2007 Jan;81(1):292-300. Epub 2006 Oct 18.

13.

4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.

Harrison JM, Bertram EM, Boyle DB, Coupar BE, Ranasinghe C, Ramshaw IA.

Vaccine. 2006 Nov 17;24(47-48):6867-74. Epub 2006 Jun 22.

PMID:
17050052
14.

Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines: implications for future trials.

De Rose R, Sullivan MT, Dale CJ, Kelleher AD, Emery S, Cooper DA, Ramshaw IA, Boyle DB, Kent SJ.

Hum Vaccin. 2006 May-Jun;2(3):134-6. Epub 2006 May 10.

PMID:
17012897
15.

Prime-boost strategies in DNA vaccines.

Dale CJ, Thomson S, De Rose R, Ranasinghe C, Medveczky CJ, Pamungkas J, Boyle DB, Ramshaw IA, Kent SJ.

Methods Mol Med. 2006;127:171-97. Review.

PMID:
16988455
16.

Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.

Ranasinghe C, Medveczky JC, Woltring D, Gao K, Thomson S, Coupar BE, Boyle DB, Ramsay AJ, Ramshaw IA.

Vaccine. 2006 Jul 26;24(31-32):5881-95. Epub 2006 May 2.

PMID:
16759767
17.

Cytokines, skin, and smallpox-a new link to an antimicrobial Peptide.

Harrison JM, Ramshaw IA.

Immunity. 2006 Mar;24(3):245-7.

18.

Recombinant fowlpox virus for in vitro gene delivery to pancreatic islet tissue.

Solomon MF, Ramshaw IA, Simeonovic CJ.

Immunol Cell Biol. 2005 Dec;83(6):615-25.

PMID:
16266313
19.

Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.

Coupar BE, Purcell DF, Thomson SA, Ramshaw IA, Kent SJ, Boyle DB.

Vaccine. 2006 Feb 27;24(9):1378-88. Epub 2005 Oct 5.

PMID:
16257479
20.

Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.

Kent SJ, Dale CJ, Ranasinghe C, Stratov I, De Rose R, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Wilson KM, Ramsay AJ.

Vaccine. 2005 Oct 10;23(42):5009-21.

PMID:
15985317
21.

Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use.

Thomson SA, Jaramillo AB, Shoobridge M, Dunstan KJ, Everett B, Ranasinghe C, Kent SJ, Gao K, Medveckzy J, Ffrench RA, Ramshaw IA.

Vaccine. 2005 Sep 7;23(38):4647-57.

PMID:
15964105
22.

Comparison of whole gene and whole virus scrambled antigen approaches for DNA prime and fowlpox virus boost HIV type 1 vaccine regimens in macaques.

Pamungkas J, De Rose R, Iskandriati D, Noviana R, Paramastri Y, Dale CJ, Shoobridge M, Medveczky CJ, Ramshaw IA, Thomson S, Kent SJ.

AIDS Res Hum Retroviruses. 2005 Apr;21(4):292-300.

PMID:
15943571
23.

The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4.

Robbins SJ, Jackson RJ, Fenner F, Beaton S, Medveczky J, Ramshaw IA, Ramsay AJ.

Antiviral Res. 2005 Apr;66(1):1-7. Epub 2005 Jan 25.

PMID:
15781125
24.

Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques.

De Rose R, Chea S, Dale CJ, Reece J, Fernandez CS, Wilson KM, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Sullivan MT, Kent SJ.

Vaccine. 2005 Mar 14;23(16):1949-56.

PMID:
15734067
25.

Enhanced cellular immunity in macaques following a novel peptide immunotherapy.

Chea S, Dale CJ, De Rose R, Ramshaw IA, Kent SJ.

J Virol. 2005 Mar;79(6):3748-57.

26.

Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus.

Dale CJ, De Rose R, Stratov I, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Kent SJ.

J Virol. 2004 Dec;78(24):13819-28.

27.

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNgamma or IL-12.

Dale CJ, De Rose R, Wilson KM, Croom HA, Thomson S, Coupar BE, Ramsay A, Purcell DF, Ffrench R, Law M, Emery S, Cooper DA, Ramshaw IA, Boyle DB, Kent SJ; Australian Thai HIV Vaccine Consortium.

Vaccine. 2004 Nov 25;23(2):188-97.

PMID:
15531036
28.

A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo.

Hamilton NH, Mahalingam S, Banyer JL, Ramshaw IA, Thomson SA.

Scand J Immunol. 2004 Mar;59(3):246-54.

30.

Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine.

Webster DE, Cooney ML, Huang Z, Drew DR, Ramshaw IA, Dry IB, Strugnell RA, Martin JL, Wesselingh SL.

J Virol. 2002 Aug;76(15):7910-2.

31.

IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).

Hamilton NH, Banyer JL, Hapel AJ, Mahalingam S, Ramsay AJ, Ramshaw IA, Thomson SA.

Scand J Immunol. 2002 Feb;55(2):171-7.

32.

Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population.

Estcourt MJ, Ramsay AJ, Brooks A, Thomson SA, Medveckzy CJ, Ramshaw IA.

Int Immunol. 2002 Jan;14(1):31-7.

PMID:
11751749
33.

Cytokines in innate and adaptive immunity.

Banyer JL, Hamilton NH, Ramshaw IA, Ramsay AJ.

Rev Immunogenet. 2000;2(3):359-73. Review.

PMID:
11256745
34.
35.
36.

Avipox virus vectors for gene delivery to fetal mouse and pig proislets.

Paule MF, Ramshaw IA, Simeonovic CJ.

Transplant Proc. 2000 Aug;32(5):1067. No abstract available.

PMID:
10936359
37.

The prime-boost strategy: exciting prospects for improved vaccination.

Ramshaw IA, Ramsay AJ.

Immunol Today. 2000 Apr;21(4):163-5. Review. No abstract available.

PMID:
10740236
38.

A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques.

Kent SJ, Zhao A, Dale CJ, Land S, Boyle DB, Ramshaw IA.

Vaccine. 2000 Apr 28;18(21):2250-6.

PMID:
10717345
39.

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

Ramsay AJ, Kent SJ, Strugnell RA, Suhrbier A, Thomson SA, Ramshaw IA.

Immunol Rev. 1999 Oct;171:27-44. Review.

PMID:
10582164
40.
41.

Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes.

Woodberry T, Gardner J, Mateo L, Eisen D, Medveczky J, Ramshaw IA, Thomson SA, Ffrench RA, Elliott SL, Firat H, Lemonnier FA, Suhrbier A.

J Virol. 1999 Jul;73(7):5320-5.

42.

Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation.

Rolph MS, Matthaei KI, Carbone FR, Heath WR, Ramshaw IA.

Viral Immunol. 1998;11(4):183-95.

PMID:
10189186
43.

Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease?

Willenborg DO, Fordham SA, O'Brien NC, Cowden WB, Ramshaw IA.

Res Immunol. 1998 Nov-Dec;149(9):804-10; discussion 849-50, 855-60. Review. No abstract available.

PMID:
9923636
45.

Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3.

Jackson RJ, Maguire DJ, Hinds LA, Ramshaw IA.

Biol Reprod. 1998 Jan;58(1):152-9.

PMID:
9472936
46.

Cytokines and immunity to viral infections.

Ramshaw IA, Ramsay AJ, Karupiah G, Rolph MS, Mahalingam S, Ruby JC.

Immunol Rev. 1997 Oct;159:119-35. Review.

PMID:
9416507
47.

DNA vaccines for the treatment of autoimmune disease.

Ramshaw IA, Fordham SA, Bernard CC, Maguire D, Cowden WB, Willenborg DO.

Immunol Cell Biol. 1997 Aug;75(4):409-13. Review.

PMID:
9315486
48.
49.

DNA immunization.

Ramsay AJ, Ramshaw IA, Ada GL.

Immunol Cell Biol. 1997 Aug;75(4):360-3. Review.

PMID:
9315478
50.

Recombinant viruses as vaccines and immunological tools.

Rolph MS, Ramshaw IA.

Curr Opin Immunol. 1997 Aug;9(4):517-24. Review.

PMID:
9287173

Supplemental Content

Loading ...
Support Center